LIDUINA BOTALLA
LIDUINA BOTALLA publishes mostly in Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics, on topics such as Pituitary Gland Disorders and Treatments, Growth Hormone and Insulin-like Growth Factors and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities.
- World rank
- #1,848,827 of 7,710,434 ranked researchers
- Rank in Italy
- #60,850 of 242,206
- Works
- 24
- Citations
- 880
- Citations per work
- 36.7
What does LIDUINA BOTALLA research?
LIDUINA BOTALLA's work is mostly in Medicine (74%), Biochemistry, Genetics and Molecular Biology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1874.0%
- Medicine1874.0%
- Everything else417.4%
- Life Sciences28.6%
- 1Endocrinology, Diabetes and Metabolism64% of their works
- 2Molecular Biology5% of their works
- 3Genetics3% of their works
- 4Oncology3% of their works
- 5Genetics3% of their works
- 6Rheumatology3% of their works
Research topics
- Pituitary Gland Disorders and Treatments
- Growth Hormone and Insulin-like Growth Factors
- Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Sexual Differentiation and Disorders
- Adrenal Hormones and Disorders
- Neuroendocrine Tumor Research Advances
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Cancer Treatment and Pharmacology
Which keywords describe LIDUINA BOTALLA's research?
The keywords of their largest research topics: Growth Hormone, Cushing's Syndrome, Pituitary Adenomas, IGF-1, Insulin-like Growth Factors, Adrenal Insufficiency, Chemotherapy-Induced Peripheral Neuropathy and Congenital Adrenal Hyperplasia.
- Taxanes
- Sex Determination
- Neuroendocrine Tumors
- Hereditary Angioedema
- Congenital Adrenal Hyperplasia
- Adrenal Insufficiency
- IGF-1
- Cushing's Syndrome
- Growth Hormone
- Pituitary Adenomas
- Insulin-like Growth Factors
- Chemotherapy-Induced Peripheral Neuropathy
- Corticosteroid Therapy
- Kinin Receptor Family
- Pancreatic Neuroendocrine Tumors
- Steroid 21-Hydroxylase Deficiency
- X Chromosome Inactivation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Growth Hormone332 topics
- Cushing's Syndrome181 topic
- Pituitary Adenomas181 topic
- IGF-1151 topic
- Insulin-like Growth Factors151 topic
- Adrenal Insufficiency21 topic
- Chemotherapy-Induced Peripheral Neuropathy21 topic
- Congenital Adrenal Hyperplasia21 topic
- Corticosteroid Therapy21 topic
- Hereditary Angioedema21 topic
- Kinin Receptor Family21 topic
- Neuroendocrine Tumors21 topic
- Pancreatic Neuroendocrine Tumors21 topic
- Sex Determination21 topic
- Steroid 21-Hydroxylase Deficiency21 topic
- Taxanes21 topic
- X Chromosome Inactivation21 topic
Where does LIDUINA BOTALLA work?
LIDUINA BOTALLA's main affiliation in the publication record is Ospedale Maggiore, Italy.
How many publications and citations does LIDUINA BOTALLA have?
OpenAlex counts 24 works and 880 citations for LIDUINA BOTALLA, an h-index of 12, ranking #1,848,827 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about LIDUINA BOTALLA. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.